Correlation between Sputum Cartridge-based Nucleic Acid Amplification Test–Cycle Threshold Values and Glycosylated Hemoglobin Levels in Patients with Pulmonary Tuberculosis
Chirag K C, Shashibhushan B L, Mohan J, Karthik A B
Citation Information :
K C C, B L S, J M, A B K. Correlation between Sputum Cartridge-based Nucleic Acid Amplification Test–Cycle Threshold Values and Glycosylated Hemoglobin Levels in Patients with Pulmonary Tuberculosis. Indian J Respir Care 2024; 13 (3):158-162.
Aims and background: India bears the brunt of both tuberculosis (TB) as well as diabetes patients globally, and either disease affects each other detrimentally, leading to increased morbidity and mortality; thereby, hampering the national and international policies and goals targeted in the control and prevention of these diseases. Hence, this study was done to determine the correlation between the sputum cartridge-based nucleic acid amplification test (CBNAAT) cycle threshold (Ct) values and glycosylated hemoglobin (HbA1c) levels at the point of diagnosing pulmonary tuberculosis (PTB).
Materials and methods: This study, conducted over a span of 6 months, followed a cross-sectional design. Patients diagnosed with PTB, confirmed by sputum CBNAAT, were enrolled in the study after screening them with the inclusion and exclusion criteria. The sputum CBNAAT Ct values were noted, and the average of the five probes labeled as A, B, C, D, and E was utilized to quantify the bacilli, reported as the mean Ct value. Semi-quantitative mycobacterial load results were categorized as follows—high (Ct values <16), medium (Ct values 16–22), low (Ct values 22–28), or very low (Ct values >28). The HbA1c (glycated hemoglobin) levels of the patients were estimated from a venous blood sample.
Results: Out of 136 study subjects, 61% were male participants with a mean age of 41 years. Among them, 23.5% (n = 32) were previously known diabetics. Additionally, 37.5% (n = 51) were newly detected diabetics based on HbA1c levels (cutoff 6.4) at the time of PTB diagnosis. Most patients had a low bacterial load (44.10%, n = 60). The high bacterial load group (26.5%, n = 36) had the lowest mean Ct value of 15.51, while the very low bacterial load group (8%, n = 8) had the highest mean Ct value of 31.47. The high bacterial load group also had the highest mean HbA1c level of 7.6, whereas the low bacterial load group had the lowest mean HbA1c level of 6.03. The Pearson correlation coefficient is −0.426, indicating a moderate negative correlation between the two variables.
Conclusion: This study found a moderate negative correlation between sputum CBNAAT Ct values and HbA1c levels in patients with pulmonary TB. This suggests that as HbA1c levels increase, the bacillary load also increases, as indicated by decreasing Ct values, and vice versa.
Clinical significance: According to our study, patients with poor glycemic control have a high bacterial load, predicting more severe disease. This finding may help guide treatment decisions and improve patient outcomes.
World Health Organization. Global tuberculosis report 2023 [Internet]. Geneva: World Health Organization; 2023 [cited 2024 Jan 14].
Kwak N, Choi SM, Lee J, et al. Diagnostic accuracy and turn around time of the Xpert MTB/RIF assay in routine clinical practice. PloS one 2013;8:e77456–e77456. DOI: 10.1371/journal.pone.0077456
Perrin FM, Woodward N, Phillips PP, et al. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010;14(12):1596–1602. PMID: 21144246.
Palaci M, Dietze R, Hadad DJ, et al. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol 2007;45(12):4064–4066. DOI: 10.1128/JCM.01780-07
World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. https://www.who.int/tb/publications/2013/xpert_policyupdate/en/ (accessed Jan 30, 2023)
Central Tuberculosis Division. INDIA TB REPORT 2023 [Internet]. Central TB Division, MoHFW, India.; 2023 Mar (Annual Reports).
Basevi V, Di Mario S, Morciano C, et al. Comment on: American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care 2011;34(Suppl. 1):S11–S61. Diabetes Care 2011;34(5):e53–e54. DOI: 10.2337/dc11-0174
Alisjahbana B, van Crevel R, Sahiratmadja E, et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006;10(6):696–700. PMID: 16776459.
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009;9(12):737–746. DOI: 10.1016/S1473-3099(09)70282-8
Semiquantitative Results Interpretation in CBNAAT | knowledge Base ntep.in https://ntep.in/node/1690/CP-semiquantitative-results-interpretation-cbnaat (cited on 30/6/2023). [11] Guidelines: Central TB Division. https://tbcindia.gov.in/index1. (Cited on: Apr 1, 2023)
Najjingo I, Muttamba W, Kirenga BJ, et al. Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- a cross-sectional study. PLoS One 2019;14(5):e0216901. DOI: 10.1371/journal.pone.0216901
Prakash AK, Datta B, Tripathy JP, et al. The clinical utility of cycle of threshold value of Gene Xpert MTB/RIF (CBNAAT) and its Diagnostic accuracy in pulmonary and extra pulmonary samples at a tertiary care centre in India. Indian J Tuberc 2018;65(4):296–302. DOI: 10.1016/j.ijtb.2018.05.021
Gupte AN, Mave V, Meshram S, et al. Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis 2018;22(7):800–806. DOI: 10.5588/ijtld.18.0026
Kim SJ, Hong YP, Lew WJ, et al. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995;76(6):529–533. DOI: 10.1016/0962-8479(95)90529-4
Lee PH, Fu H, Lai TC, et al. Glycemic control and the risk of tuberculosis: a cohort study. PLoS Med 2016;13(8):e1002072. DOI: 10.1371/journal.pmed.1002072
Berkowitz N, Okorie A, Goliath R, et al. The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting. Diabetes Res Clin Pract 2018;138:16–25. DOI: 10.1016/j.dia bres.2018.01.018
Martínez-Aguilar G, Serrano CJ, Castañeda-Delgado JE, et al. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Arch Med Res 2015;46(3):221–227. DOI: 10.1016/j.arcmed.2015.03.009
Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Pneumonia Infect Dis Clin North Am 1995;9(1):65–96. PMID: 7769221.
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009;9(12):737–746. DOI: 10.1016/S1473-3099(09)70282-8
Hensel RL, Kempker RR, Tapia J, et al. Increased risk of latent tuberculous infection among persons with prediabetes and diabetes mellitus. Int J Tuberc Lung Dis 2016;20(1):71–78. DOI: 10.5588/ijtld.15.0457
Sanchez-Jimenez R, Ceron E, Bernal-Alcantara D, et al. Association between IL-15 and insulin plasmatic concentrations in patients with pulmonary tuberculosis and type 2 diabetes. Tuberculosis (Edinb) 2018;111:114–120. DOI: 10.1016/j.tube.2018.06.009
Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007;3(3):228–245. DOI: 10.1177/1742395307081502
Restrepo BI, Fisher Hoch SP, Pino PA, et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 2008;47(5):634–641. DOI: 10.1086/590565
Kassa D, Ran L, Geberemeskel W, et al. Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis. Clin Vaccine Immunol 2012;19(12):1907–1915. DOI: 10.1128/CVI.00482-12
Hodgson K, Morris J, Bridson T, et al. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 2015;144(2):171–185. DOI: 10.1111/imm.12394